Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vanda Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- −9 vs. Q4 2021
- Shares held
- 56.3M
- +2.02M (+3.7%) vs. Q4 2021
- Total value
- $636.7M
- −$214.7M (−25.2%) vs. Q4 2021
- New holders
- 22
- 63 more added
- Sold out
- 31
- 74 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $304.1M |
| Q1 2026 | 171 | $319.4M |
| Q4 2025 | 153 | $369.4M |
| Q3 2025 | 150 | $224.0M |
| Q2 2025 | 140 | $212.4M |
| Q1 2025 | 146 | $202.1M |
| Q4 2024 | 146 | $206.7M |
| Q3 2024 | 152 | $206.3M |
| Q2 2024 | 148 | $246.0M |
| Q1 2024 | 144 | $198.0M |
| Q4 2023 | 157 | $213.8M |
| Q3 2023 | 180 | $227.2M |
| Q2 2023 | 188 | $370.7M |
| Q1 2023 | 178 | $395.9M |
| Q4 2022 | 190 | $410.0M |
| Q3 2022 | 178 | $544.1M |
| Q2 2022 | 174 | $610.6M |
| Q1 2022 | 188 | $636.7M |
| Q4 2021 | 198 | $851.4M |
| Q3 2021 | 182 | $946.9M |
| Q2 2021 | 181 | $1.18B |
| Q1 2021 | 189 | $820.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vanda Pharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −24,450−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −18,994−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −15,819−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −14,280−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −11,180−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −10,698−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −10,227−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −6,250−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −3,914−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −3,223−100.0% | Sold out |
| Signet Financial Management, LLC | 0 | $0 | 0.00% | −2,335−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −633−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −536−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |